Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms

Table 1 Characteristics of the 142 patients with gastric neuroendocrine neoplasms with different tumor-associated neutrophil-to-lymphocyte ratios

Clinicopathological feature	TA-NLR		Univariate analysis	Multivariate analysis
	≤ 0.21 (n = 71)	> 0.21 (n = 71)	P value	P value
Age (yr)			0.322
≤ 70	57	52
> 70	14	19
Gender			0.851
Male	52	51
Female	19	20
Tumor site			0.099
Upper	39	26
Middle	10	15
Lower	17	18
Mixed	5	12
Tumor size (cm)			0.593
≤ 3.5	25	22
> 3.5	46	49
Ki-67 index (%)			0.081
≤ 2	13	6
≥ 3, ≤ 20	8	16
>20	50	49
Depth of invasion			0.044	0.406
T1	14	8
T2	7	3
T3	34	29
T4	16	31
Lymph node ratio			0.043	0.355
0	25	13
> 0, ≤ 0.2	25	24
> 0.2, ≤ 0.4	15	18
> 0.4	6	16
Lymphovascular invasion			0.610
No	43	40
Yes	28	31
ASA status			0.805
1 + 2	61	62
3 + 4	10	9
Postoperative complication			0.041	0.071
No	57	46
Yes	14	25
Surgical approach			0.855
Endo/laparoscopic	49	50
Open	22	21

TA-NLR: Tumor-associated neutrophil-to-lymphocyte ratio.